nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—HTR2A—pancreatitis	0.542	1	CbGaD
Haloperidol—Heat stroke—Propantheline—pancreatitis	0.0438	0.177	CcSEcCtD
Haloperidol—Hyperpyrexia—Hyoscyamine—pancreatitis	0.011	0.0445	CcSEcCtD
Haloperidol—Loss of libido—Hyoscyamine—pancreatitis	0.00887	0.0359	CcSEcCtD
Haloperidol—Salivary hypersecretion—Propantheline—pancreatitis	0.00777	0.0315	CcSEcCtD
Haloperidol—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00638	0.0258	CcSEcCtD
Haloperidol—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.00553	0.0224	CcSEcCtD
Haloperidol—Laryngospasm—Hyoscyamine—pancreatitis	0.00548	0.0222	CcSEcCtD
Haloperidol—Ventricular fibrillation—Hyoscyamine—pancreatitis	0.00535	0.0217	CcSEcCtD
Haloperidol—Dysphagia—Propantheline—pancreatitis	0.00502	0.0203	CcSEcCtD
Haloperidol—Extrasystoles—Hyoscyamine—pancreatitis	0.00486	0.0197	CcSEcCtD
Haloperidol—Erectile dysfunction—Propantheline—pancreatitis	0.00462	0.0187	CcSEcCtD
Haloperidol—Drowsiness—Propantheline—pancreatitis	0.00447	0.0181	CcSEcCtD
Haloperidol—Leukocytosis—Hyoscyamine—pancreatitis	0.00436	0.0177	CcSEcCtD
Haloperidol—Muscle twitching—Hyoscyamine—pancreatitis	0.00417	0.0169	CcSEcCtD
Haloperidol—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.00409	0.0166	CcSEcCtD
Haloperidol—Injection site reaction—Hyoscyamine—pancreatitis	0.00407	0.0165	CcSEcCtD
Haloperidol—Hypertonia—Hyoscyamine—pancreatitis	0.00359	0.0145	CcSEcCtD
Haloperidol—Hyperkinesia—Hyoscyamine—pancreatitis	0.00357	0.0145	CcSEcCtD
Haloperidol—Vision blurred—Propantheline—pancreatitis	0.00329	0.0134	CcSEcCtD
Haloperidol—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00304	0.0123	CcSEcCtD
Haloperidol—Lethargy—Hyoscyamine—pancreatitis	0.00303	0.0123	CcSEcCtD
Haloperidol—Hyponatraemia—Hyoscyamine—pancreatitis	0.00298	0.0121	CcSEcCtD
Haloperidol—Dry mouth—Propantheline—pancreatitis	0.00291	0.0118	CcSEcCtD
Haloperidol—Psychotic disorder—Hyoscyamine—pancreatitis	0.0029	0.0118	CcSEcCtD
Haloperidol—Confusional state—Propantheline—pancreatitis	0.00288	0.0117	CcSEcCtD
Haloperidol—Anaphylactic shock—Propantheline—pancreatitis	0.00285	0.0116	CcSEcCtD
Haloperidol—Urinary retention—Hyoscyamine—pancreatitis	0.00283	0.0115	CcSEcCtD
Haloperidol—Cardiac arrest—Hyoscyamine—pancreatitis	0.00283	0.0115	CcSEcCtD
Haloperidol—Tachycardia—Propantheline—pancreatitis	0.00278	0.0113	CcSEcCtD
Haloperidol—Insomnia—Propantheline—pancreatitis	0.00258	0.0105	CcSEcCtD
Haloperidol—Dysphagia—Hyoscyamine—pancreatitis	0.00257	0.0104	CcSEcCtD
Haloperidol—Somnolence—Propantheline—pancreatitis	0.00254	0.0103	CcSEcCtD
Haloperidol—Constipation—Propantheline—pancreatitis	0.00244	0.00989	CcSEcCtD
Haloperidol—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00237	0.00959	CcSEcCtD
Haloperidol—Feeling abnormal—Propantheline—pancreatitis	0.00235	0.00953	CcSEcCtD
Haloperidol—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00232	0.00939	CcSEcCtD
Haloperidol—Drowsiness—Hyoscyamine—pancreatitis	0.00229	0.00928	CcSEcCtD
Haloperidol—Depression—Hyoscyamine—pancreatitis	0.00228	0.00925	CcSEcCtD
Haloperidol—Urticaria—Propantheline—pancreatitis	0.00227	0.00919	CcSEcCtD
Haloperidol—Hypersensitivity—Propantheline—pancreatitis	0.0021	0.00852	CcSEcCtD
Haloperidol—Hallucination—Hyoscyamine—pancreatitis	0.00205	0.00829	CcSEcCtD
Haloperidol—Dizziness—Propantheline—pancreatitis	0.00189	0.00765	CcSEcCtD
Haloperidol—Vomiting—Propantheline—pancreatitis	0.00181	0.00735	CcSEcCtD
Haloperidol—Mental disorder—Hyoscyamine—pancreatitis	0.0018	0.0073	CcSEcCtD
Haloperidol—Rash—Propantheline—pancreatitis	0.0018	0.00729	CcSEcCtD
Haloperidol—Dermatitis—Propantheline—pancreatitis	0.0018	0.00728	CcSEcCtD
Haloperidol—Headache—Propantheline—pancreatitis	0.00179	0.00724	CcSEcCtD
Haloperidol—Droperidol—HTR2A—pancreatitis	0.00174	0.461	CrCbGaD
Haloperidol—Nausea—Propantheline—pancreatitis	0.00169	0.00687	CcSEcCtD
Haloperidol—Vision blurred—Hyoscyamine—pancreatitis	0.00169	0.00683	CcSEcCtD
Haloperidol—Agitation—Hyoscyamine—pancreatitis	0.00164	0.00666	CcSEcCtD
Haloperidol—Vertigo—Hyoscyamine—pancreatitis	0.00161	0.00652	CcSEcCtD
Haloperidol—Convulsion—Hyoscyamine—pancreatitis	0.00155	0.00628	CcSEcCtD
Haloperidol—Anxiety—Hyoscyamine—pancreatitis	0.00152	0.00615	CcSEcCtD
Haloperidol—Dry mouth—Hyoscyamine—pancreatitis	0.00149	0.00604	CcSEcCtD
Haloperidol—Confusional state—Hyoscyamine—pancreatitis	0.00147	0.00597	CcSEcCtD
Haloperidol—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00146	0.00592	CcSEcCtD
Haloperidol—Oedema—Hyoscyamine—pancreatitis	0.00146	0.00592	CcSEcCtD
Haloperidol—Tachycardia—Hyoscyamine—pancreatitis	0.00143	0.00578	CcSEcCtD
Haloperidol—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00141	0.00572	CcSEcCtD
Haloperidol—Hypotension—Hyoscyamine—pancreatitis	0.00136	0.00553	CcSEcCtD
Haloperidol—Insomnia—Hyoscyamine—pancreatitis	0.00132	0.00535	CcSEcCtD
Haloperidol—Dyspnoea—Hyoscyamine—pancreatitis	0.0013	0.00528	CcSEcCtD
Haloperidol—Somnolence—Hyoscyamine—pancreatitis	0.0013	0.00526	CcSEcCtD
Haloperidol—Dyspepsia—Hyoscyamine—pancreatitis	0.00129	0.00521	CcSEcCtD
Haloperidol—Constipation—Hyoscyamine—pancreatitis	0.00125	0.00506	CcSEcCtD
Haloperidol—Feeling abnormal—Hyoscyamine—pancreatitis	0.0012	0.00488	CcSEcCtD
Haloperidol—Urticaria—Hyoscyamine—pancreatitis	0.00116	0.0047	CcSEcCtD
Haloperidol—Body temperature increased—Hyoscyamine—pancreatitis	0.00115	0.00468	CcSEcCtD
Haloperidol—Sertindole—HTR2A—pancreatitis	0.00112	0.297	CrCbGaD
Haloperidol—Hypersensitivity—Hyoscyamine—pancreatitis	0.00108	0.00436	CcSEcCtD
Haloperidol—Pruritus—Hyoscyamine—pancreatitis	0.00103	0.00419	CcSEcCtD
Haloperidol—Diarrhoea—Hyoscyamine—pancreatitis	0.000999	0.00405	CcSEcCtD
Haloperidol—CBR1—islet of Langerhans—pancreatitis	0.000969	0.0766	CbGeAlD
Haloperidol—Dizziness—Hyoscyamine—pancreatitis	0.000966	0.00391	CcSEcCtD
Haloperidol—Vomiting—Hyoscyamine—pancreatitis	0.000929	0.00376	CcSEcCtD
Haloperidol—Rash—Hyoscyamine—pancreatitis	0.000921	0.00373	CcSEcCtD
Haloperidol—Dermatitis—Hyoscyamine—pancreatitis	0.00092	0.00373	CcSEcCtD
Haloperidol—Headache—Hyoscyamine—pancreatitis	0.000915	0.00371	CcSEcCtD
Haloperidol—Fluspirilene—HTR2A—pancreatitis	0.000913	0.242	CrCbGaD
Haloperidol—Nausea—Hyoscyamine—pancreatitis	0.000867	0.00352	CcSEcCtD
Haloperidol—H1F0—islet of Langerhans—pancreatitis	0.000794	0.0627	CbGeAlD
Haloperidol—UGT1A9—digestive system—pancreatitis	0.000773	0.0611	CbGeAlD
Haloperidol—CBR1—digestive system—pancreatitis	0.000582	0.046	CbGeAlD
Haloperidol—SIGMAR1—islet of Langerhans—pancreatitis	0.000573	0.0453	CbGeAlD
Haloperidol—H1F0—pancreas—pancreatitis	0.000558	0.0441	CbGeAlD
Haloperidol—CBR1—blood—pancreatitis	0.000554	0.0438	CbGeAlD
Haloperidol—H1F0—digestive system—pancreatitis	0.000476	0.0377	CbGeAlD
Haloperidol—KCNH2—islet of Langerhans—pancreatitis	0.000456	0.0361	CbGeAlD
Haloperidol—H1F0—blood—pancreatitis	0.000454	0.0359	CbGeAlD
Haloperidol—SIGMAR1—pancreas—pancreatitis	0.000403	0.0319	CbGeAlD
Haloperidol—CYP3A5—islet of Langerhans—pancreatitis	0.000377	0.0298	CbGeAlD
Haloperidol—HTR2B—digestive system—pancreatitis	0.000343	0.0271	CbGeAlD
Haloperidol—SIGMAR1—blood—pancreatitis	0.000328	0.0259	CbGeAlD
Haloperidol—HTR2B—blood—pancreatitis	0.000327	0.0259	CbGeAlD
Haloperidol—CYP2C19—digestive system—pancreatitis	0.000287	0.0227	CbGeAlD
Haloperidol—CYP2C19—blood—pancreatitis	0.000274	0.0216	CbGeAlD
Haloperidol—CYP3A5—pancreas—pancreatitis	0.000265	0.0209	CbGeAlD
Haloperidol—KCNH2—blood—pancreatitis	0.000261	0.0206	CbGeAlD
Haloperidol—CYP1A2—digestive system—pancreatitis	0.000235	0.0185	CbGeAlD
Haloperidol—CYP1A1—digestive system—pancreatitis	0.000231	0.0183	CbGeAlD
Haloperidol—CYP3A5—digestive system—pancreatitis	0.000226	0.0179	CbGeAlD
Haloperidol—CYP1A2—blood—pancreatitis	0.000223	0.0177	CbGeAlD
Haloperidol—CYP2C9—digestive system—pancreatitis	0.000223	0.0176	CbGeAlD
Haloperidol—CYP1A1—blood—pancreatitis	0.00022	0.0174	CbGeAlD
Haloperidol—HRH1—digestive system—pancreatitis	0.00022	0.0174	CbGeAlD
Haloperidol—CYP3A5—blood—pancreatitis	0.000215	0.017	CbGeAlD
Haloperidol—CYP2C9—blood—pancreatitis	0.000212	0.0168	CbGeAlD
Haloperidol—ABCB1—islet of Langerhans—pancreatitis	0.0002	0.0158	CbGeAlD
Haloperidol—HTR2A—digestive system—pancreatitis	0.000183	0.0145	CbGeAlD
Haloperidol—HTR2A—blood—pancreatitis	0.000175	0.0138	CbGeAlD
Haloperidol—CYP3A4—digestive system—pancreatitis	0.00017	0.0134	CbGeAlD
Haloperidol—CYP2D6—digestive system—pancreatitis	0.000167	0.0132	CbGeAlD
Haloperidol—CYP3A4—blood—pancreatitis	0.000162	0.0128	CbGeAlD
Haloperidol—CYP2D6—blood—pancreatitis	0.000159	0.0126	CbGeAlD
Haloperidol—ABCB1—pancreas—pancreatitis	0.000141	0.0111	CbGeAlD
Haloperidol—ABCB1—digestive system—pancreatitis	0.00012	0.0095	CbGeAlD
Haloperidol—ABCB1—blood—pancreatitis	0.000114	0.00905	CbGeAlD
Haloperidol—CYP2C19—Metabolism—ALDH2—pancreatitis	1.98e-05	0.000102	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GCG—pancreatitis	1.98e-05	0.000102	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—A2M—pancreatitis	1.98e-05	0.000101	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HTR2A—pancreatitis	1.97e-05	0.000101	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SPP1—pancreatitis	1.95e-05	9.99e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GCG—pancreatitis	1.95e-05	9.99e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—LEP—pancreatitis	1.95e-05	9.98e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GCG—pancreatitis	1.94e-05	9.97e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GCG—pancreatitis	1.94e-05	9.96e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CXCL8—pancreatitis	1.94e-05	9.95e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALDH2—pancreatitis	1.93e-05	9.92e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.93e-05	9.91e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SPP1—pancreatitis	1.92e-05	9.86e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—LEP—pancreatitis	1.92e-05	9.83e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CXCL8—pancreatitis	1.92e-05	9.82e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KNG1—pancreatitis	1.9e-05	9.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KNG1—pancreatitis	1.87e-05	9.59e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KNG1—pancreatitis	1.87e-05	9.57e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.86e-05	9.52e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HTR2A—pancreatitis	1.86e-05	9.51e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CCL2—pancreatitis	1.85e-05	9.5e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GCG—pancreatitis	1.84e-05	9.41e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HTR2A—pancreatitis	1.83e-05	9.39e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PPARG—pancreatitis	1.83e-05	9.39e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—LEP—pancreatitis	1.83e-05	9.38e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CCL2—pancreatitis	1.82e-05	9.35e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALDH2—pancreatitis	1.82e-05	9.35e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CCL2—pancreatitis	1.82e-05	9.33e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—XDH—pancreatitis	1.81e-05	9.3e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALDH2—pancreatitis	1.81e-05	9.27e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—INS—pancreatitis	1.8e-05	9.21e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—NRAS—pancreatitis	1.8e-05	9.2e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.76e-05	9.03e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—NRAS—pancreatitis	1.76e-05	9.01e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PLA2G1B—pancreatitis	1.75e-05	8.96e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PDGFA—pancreatitis	1.75e-05	8.96e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.74e-05	8.91e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—NRAS—pancreatitis	1.73e-05	8.87e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—LEP—pancreatitis	1.73e-05	8.85e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PDGFA—pancreatitis	1.72e-05	8.82e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PDGFA—pancreatitis	1.72e-05	8.8e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—LEP—pancreatitis	1.7e-05	8.73e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—INS—pancreatitis	1.7e-05	8.71e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADH1B—pancreatitis	1.69e-05	8.67e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—A2M—pancreatitis	1.69e-05	8.66e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCL2—pancreatitis	1.67e-05	8.57e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—INS—pancreatitis	1.66e-05	8.53e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—NRAS—pancreatitis	1.65e-05	8.46e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—ALB—pancreatitis	1.65e-05	8.44e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—INS—pancreatitis	1.64e-05	8.39e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCL2—pancreatitis	1.64e-05	8.39e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CXCL8—pancreatitis	1.61e-05	8.27e-05	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.61e-05	8.27e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCL2—pancreatitis	1.61e-05	8.26e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL5—pancreatitis	1.59e-05	8.15e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	1.59e-05	8.14e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CXCL8—pancreatitis	1.58e-05	8.12e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.58e-05	8.12e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL5—pancreatitis	1.56e-05	8.02e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—INS—pancreatitis	1.56e-05	8.01e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL5—pancreatitis	1.56e-05	8e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—NRAS—pancreatitis	1.56e-05	7.98e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LPL—pancreatitis	1.55e-05	7.97e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—KRAS—pancreatitis	1.55e-05	7.92e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALDH2—pancreatitis	1.54e-05	7.92e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PPARG—pancreatitis	1.54e-05	7.89e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCL2—pancreatitis	1.54e-05	7.88e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—NRAS—pancreatitis	1.54e-05	7.88e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LPL—pancreatitis	1.53e-05	7.84e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LPL—pancreatitis	1.53e-05	7.82e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—LPL—pancreatitis	1.52e-05	7.82e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.52e-05	7.79e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—KRAS—pancreatitis	1.51e-05	7.76e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—INS—pancreatitis	1.51e-05	7.74e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.51e-05	7.72e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GCG—pancreatitis	1.5e-05	7.7e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—KRAS—pancreatitis	1.49e-05	7.63e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—INS—pancreatitis	1.47e-05	7.56e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SPP1—pancreatitis	1.47e-05	7.55e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GCG—pancreatitis	1.47e-05	7.52e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CXCL8—pancreatitis	1.47e-05	7.51e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—INS—pancreatitis	1.45e-05	7.46e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCL2—pancreatitis	1.45e-05	7.43e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SPP1—pancreatitis	1.45e-05	7.42e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SPP1—pancreatitis	1.45e-05	7.41e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	1.44e-05	7.39e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—LPL—pancreatitis	1.44e-05	7.38e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTGS2—pancreatitis	1.44e-05	7.38e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CXCL8—pancreatitis	1.44e-05	7.38e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCL2—pancreatitis	1.43e-05	7.34e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—KRAS—pancreatitis	1.42e-05	7.29e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MDM2—pancreatitis	1.41e-05	7.25e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HTR2A—pancreatitis	1.4e-05	7.18e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.39e-05	7.11e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ALB—pancreatitis	1.38e-05	7.1e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MDM2—pancreatitis	1.38e-05	7.1e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GCG—pancreatitis	1.38e-05	7.08e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HTR2A—pancreatitis	1.38e-05	7.05e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GCG—pancreatitis	1.37e-05	7.02e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MDM2—pancreatitis	1.36e-05	6.98e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.35e-05	6.94e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.35e-05	6.92e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—KRAS—pancreatitis	1.34e-05	6.87e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—KRAS—pancreatitis	1.32e-05	6.78e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CXCL8—pancreatitis	1.32e-05	6.78e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—HRAS—pancreatitis	1.31e-05	6.73e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—A2M—pancreatitis	1.3e-05	6.68e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LEP—pancreatitis	1.3e-05	6.68e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MDM2—pancreatitis	1.3e-05	6.67e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CXCL8—pancreatitis	1.29e-05	6.64e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—HRAS—pancreatitis	1.29e-05	6.59e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LEP—pancreatitis	1.28e-05	6.57e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LEP—pancreatitis	1.28e-05	6.56e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CXCL8—pancreatitis	1.27e-05	6.53e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—HRAS—pancreatitis	1.27e-05	6.49e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CASP3—pancreatitis	1.27e-05	6.49e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL6—pancreatitis	1.26e-05	6.44e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CASP3—pancreatitis	1.24e-05	6.35e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL6—pancreatitis	1.23e-05	6.31e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MDM2—pancreatitis	1.23e-05	6.29e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CASP3—pancreatitis	1.22e-05	6.25e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CXCL8—pancreatitis	1.22e-05	6.23e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—pancreatitis	1.21e-05	6.21e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL6—pancreatitis	1.21e-05	6.21e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MDM2—pancreatitis	1.21e-05	6.2e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—HRAS—pancreatitis	1.21e-05	6.19e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALDH2—pancreatitis	1.19e-05	6.11e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.18e-05	6.07e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—LPL—pancreatitis	1.18e-05	6.04e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—NRAS—pancreatitis	1.18e-05	6.03e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GCG—pancreatitis	1.17e-05	6e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CASP3—pancreatitis	1.16e-05	5.97e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—NRAS—pancreatitis	1.16e-05	5.93e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL6—pancreatitis	1.16e-05	5.93e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—NRAS—pancreatitis	1.15e-05	5.92e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—LPL—pancreatitis	1.15e-05	5.9e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CXCL8—pancreatitis	1.15e-05	5.88e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—HRAS—pancreatitis	1.14e-05	5.84e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CXCL8—pancreatitis	1.13e-05	5.8e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—HRAS—pancreatitis	1.12e-05	5.76e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PPARG—pancreatitis	1.11e-05	5.71e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—INS—pancreatitis	1.11e-05	5.71e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—pancreatitis	1.1e-05	5.63e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—INS—pancreatitis	1.1e-05	5.61e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL2—pancreatitis	1.1e-05	5.61e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—INS—pancreatitis	1.09e-05	5.6e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—INS—pancreatitis	1.09e-05	5.6e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—pancreatitis	1.09e-05	5.59e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LPL—pancreatitis	1.08e-05	5.56e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—pancreatitis	1.08e-05	5.55e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL2—pancreatitis	1.08e-05	5.52e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—pancreatitis	1.08e-05	5.52e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL2—pancreatitis	1.08e-05	5.51e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LPL—pancreatitis	1.07e-05	5.51e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NRAS—pancreatitis	1.06e-05	5.44e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—pancreatitis	1.05e-05	5.39e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NRAS—pancreatitis	1.04e-05	5.32e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—INS—pancreatitis	1.03e-05	5.29e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NRAS—pancreatitis	1.02e-05	5.24e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—KRAS—pancreatitis	1.01e-05	5.19e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—pancreatitis	1e-05	5.13e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—KRAS—pancreatitis	9.96e-06	5.1e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—KRAS—pancreatitis	9.94e-06	5.09e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—pancreatitis	9.85e-06	5.05e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NRAS—pancreatitis	9.75e-06	5e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—pancreatitis	9.65e-06	4.95e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—pancreatitis	9.5e-06	4.87e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—pancreatitis	9.46e-06	4.85e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MDM2—pancreatitis	9.26e-06	4.75e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NRAS—pancreatitis	9.2e-06	4.72e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LPL—pancreatitis	9.19e-06	4.71e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KRAS—pancreatitis	9.13e-06	4.68e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MDM2—pancreatitis	9.11e-06	4.67e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MDM2—pancreatitis	9.09e-06	4.66e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NRAS—pancreatitis	9.08e-06	4.65e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—pancreatitis	9.06e-06	4.65e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GCG—pancreatitis	9.03e-06	4.63e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KRAS—pancreatitis	8.94e-06	4.58e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KRAS—pancreatitis	8.8e-06	4.51e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—pancreatitis	8.76e-06	4.49e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—pancreatitis	8.66e-06	4.44e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—pancreatitis	8.61e-06	4.41e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—pancreatitis	8.6e-06	4.41e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—pancreatitis	8.55e-06	4.38e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—pancreatitis	8.52e-06	4.37e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—pancreatitis	8.5e-06	4.36e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—pancreatitis	8.46e-06	4.34e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—pancreatitis	8.45e-06	4.33e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—INS—pancreatitis	8.44e-06	4.33e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—pancreatitis	8.43e-06	4.32e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—pancreatitis	8.4e-06	4.31e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KRAS—pancreatitis	8.4e-06	4.3e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—pancreatitis	8.29e-06	4.25e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—pancreatitis	8.27e-06	4.24e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—INS—pancreatitis	8.24e-06	4.22e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—pancreatitis	8.23e-06	4.22e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—pancreatitis	8.15e-06	4.18e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—pancreatitis	8.14e-06	4.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—pancreatitis	8.1e-06	4.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—pancreatitis	8.08e-06	4.14e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KRAS—pancreatitis	7.92e-06	4.06e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—pancreatitis	7.92e-06	4.06e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—pancreatitis	7.85e-06	4.02e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KRAS—pancreatitis	7.81e-06	4e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—INS—pancreatitis	7.76e-06	3.98e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—pancreatitis	7.76e-06	3.98e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—pancreatitis	7.74e-06	3.97e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—INS—pancreatitis	7.7e-06	3.95e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—pancreatitis	7.6e-06	3.89e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—pancreatitis	7.55e-06	3.87e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—pancreatitis	7.48e-06	3.83e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—pancreatitis	7.43e-06	3.81e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—pancreatitis	7.27e-06	3.73e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—pancreatitis	7.16e-06	3.67e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—pancreatitis	7.14e-06	3.66e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—pancreatitis	7.12e-06	3.65e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LPL—pancreatitis	7.09e-06	3.63e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—pancreatitis	7.06e-06	3.62e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NRAS—pancreatitis	6.95e-06	3.56e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NRAS—pancreatitis	6.83e-06	3.5e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—pancreatitis	6.83e-06	3.5e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NRAS—pancreatitis	6.82e-06	3.5e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—pancreatitis	6.77e-06	3.47e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—pancreatitis	6.73e-06	3.45e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—pancreatitis	6.71e-06	3.44e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—pancreatitis	6.64e-06	3.4e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—pancreatitis	6.61e-06	3.39e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—INS—pancreatitis	6.58e-06	3.37e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—pancreatitis	6.45e-06	3.31e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—pancreatitis	6.44e-06	3.3e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—pancreatitis	6.36e-06	3.26e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—pancreatitis	6.35e-06	3.26e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—pancreatitis	6.34e-06	3.25e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—pancreatitis	6.23e-06	3.19e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—pancreatitis	6.17e-06	3.16e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—pancreatitis	6.03e-06	3.09e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KRAS—pancreatitis	5.98e-06	3.06e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KRAS—pancreatitis	5.88e-06	3.02e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KRAS—pancreatitis	5.87e-06	3.01e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—pancreatitis	5.28e-06	2.7e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—pancreatitis	5.18e-06	2.65e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—pancreatitis	5.08e-06	2.6e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—INS—pancreatitis	5.08e-06	2.6e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—pancreatitis	5e-06	2.56e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—pancreatitis	4.99e-06	2.56e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—pancreatitis	4.86e-06	2.49e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—pancreatitis	4.79e-06	2.45e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—pancreatitis	4.77e-06	2.45e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—pancreatitis	4.65e-06	2.39e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—pancreatitis	4.07e-06	2.09e-05	CbGpPWpGaD
